Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial - Hudson, MP; Armstrong, PW; Ruzyllo, W (J Am Coll Cardiol, 2006)
et al.